
The development of monoclonal antibodies has fundamentally altered the landscape of modern medicine. These treatments offer highly targeted interventions for oncology, autoimmune disorders, and infectious diseases. However, the most potent antibodies discovered through traditional hybridoma technologies in mice are inherently foreign to the human body. When doctors administer these murine proteins to patients, the…